“Many people with high-function depression are chasing goals that are mostly materialistic, like getting an accolade or ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

While there are many treatment options for depression, natural remedies, self-care methods, and alternative therapies can ...

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...

Depressed drinkers experience alcohol’s pleasure and stimulation, challenging beliefs about self-medication and addiction.

People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive ...

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda Pharmaceutical Co Ltd (NYSE:TAK) to develop and ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.